ACTRN12617000477325已完成不适用
A phase I, placebo controlled, dose escalation safety and pharmacokinetic study of (Z)-Endoxifen in healthy female volunteers.
Atossa Genetics, Inc.0 个研究点目标入组 48 人开始时间: 2017年4月3日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A phase I, placebo controlled, dose escalation safety andpharmacokinetic study of Topical Endoxifen in healthy male volunteers.Metabolic and Endocrine - Other endocrine disordersGynecomastiaACTRN12618000569202Atossa Genetics, Inc.24
已完成
不适用
A phase 1, placebo-controlled, ascending-dose study to assess the safety and imaging characteristics of GE-137 Injection in healthy volunteers, and to assess its safety and imaging characteristics in subjects with high suspicion of colorectal cancerColorectal cancerNL-OMON36432GE Healthcare35
已完成
1 期
A Phase 1, single dose, dose-ascending study of VRS-859, to observe the safety, tolerability and effect in Patients with Type 2 Diabetes MellitusMetabolic and Endocrine - DiabetesType 2 Diabetes MellitusACTRN12610000839000Versartis Inc.15
Unknown
1 期
Malaria vaccine study in healthy Indian adult males.CTRI/2020/03/023739ICGEB
已完成
不适用
First-in-human, placebo-controlled, ascending dose study to assess the safety, tolerability and pharmacokinetics of a single intratympanic injection of AC102 in healthy volunteersnow healty volunteers)tinnitus (at a later stage10019243hearing impairmentNL-OMON55334AudioCure Pharma GmbH42